carboplatin
Showing 1 - 4 of 4
Squamous Cell Carcinoma of the Head and Neck, Paclitaxel, Carboplatin Trial in Amiens (GCP intratumoral catheter)
Not yet recruiting
- Squamous Cell Carcinoma of the Head and Neck
- +3 more
- intratumoral catheter
-
Amiens, Picardie, FranceCHU Amiens Picardie
Apr 26, 2023
Triple Negative Metastatic Breast Cancer, Advanced Ovarian Cancer, Carboplatin Trial in Belgium, Netherlands, United Kingdom
Active, not recruiting
- Triple Negative Metastatic Breast Cancer
- +3 more
- KU-0059436 (AZD2281)(PARP inhibitor)
- +3 more
-
Brussels, Belgium
- +3 more
Dec 19, 2022
Urothelial Carcinoma, Anlotinib, Urogenital Tumors Trial in Tianjin (Anlotinib, Cisplatin, Carboplatin)
Not yet recruiting
- Urothelial Carcinoma
- +6 more
- Anlotinib
- +3 more
-
Tianjin, ChinaTianjin Medical Unversity Second Hospital
Aug 30, 2021
Cisplatin, Carboplatin, NPC Trial in Guangzhou (Docetaxel,Carboplatin, Docetaxel,Cisplatin, Carboplatin-based concurrent
Recruiting
- Cisplatin
- +2 more
- Docetaxel,Carboplatin
- +3 more
-
Guangzhou, Guangdong, ChinaSouthern medical university
Apr 14, 2019